To help guide iRemedy’s leadership and technology teams on this highly advanced initiative, the Company has engaged world leading AI authority Dr. David Nahamoo to serve as an AI advisor.

Dr. Nahamoo, who retired from IBM early 2018 after 35 years of service, has championed IBM’s worldwide efforts to realize spoken language as the inevitable mode of interaction with digital systems. His research in the areas of acoustic modeling, training and resource-optimized implementations has been at the core of IBM’s Automatic Speech Recognition engines for years and has earned him more than 40 patents. From 2008 until recently, Dr. Nahamoo served as Speech Chief Technology Officer at IBM Research, responsible for technical and business strategy directions for speech technologies and for providing technical direction for Conversational and Multimodal Interaction Technologies at IBM Research Labs Worldwide.

During the last 4 years, Dr. Nahamoo was the Conversation Chief Scientist at IBM Research and responsible for the delivery of the technologies for the Watson Conversation Service offerings. After earning a B.S. degree from Tehran University, an M.S. degree from Imperial College of London and a Ph.D. degree from Pursue University, he joined IBM in 1982 as a research staff member. Rising through the ranks, he was appointed Senior Manager of the Human Language Technologies Group in 1993 and became the Department Group Manager in 1998. From 1993 to 2006, he was tasked with delivering speech technologies to IBM Divisions for desktop, embedded, and server-based speech products. During these years, he was responsible for the technical direction of more than 100 IBM Scientists World Wide. In 2008, he was named an IBM Fellow.